Altered Mental Status in HIV-Infected Patients

Emergency Medicine Clinics of North America

Volumn 28, Issue 2, 2010, Pages 311-323

  Ho, Emily L ^a,b   Jay, Cheryl A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

AIDS; Altered mental status; Central nervous system infection; Human immunodeficiency virus

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPICILLIN; CEFTRIAXONE; COTRIMOXAZOLE; DEXAMETHASONE; FLUCYTOSINE; FOLINIC ACID; FOSCARNET; GANCICLOVIR; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; PYRIMETHAMINE; SULFADIAZINE; VANCOMYCIN;

AIDS RELATED COMPLEX; ANAMNESIS; APHASIA; BACTERIAL MENINGITIS; BLOOD CELL COUNT; BRAIN ABSCESS; BRAIN DYSFUNCTION; BRAIN LYMPHOMA; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; CRYPTOCOCCAL MENINGITIS; CYTOMEGALOVIRUS ENCEPHALITIS; CYTOMEGALOVIRUS INFECTION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; EMERGENCY WARD; EPSTEIN BARR VIRUS INFECTION; HEADACHE; HEMIANOPIA; HEMIPARESIS; HERPES ZOSTER ENCEPHALITIS; HIGH RISK POPULATION; HIV ASSOCIATED DEMENTIA; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INCONTINENCE; INJURY; LABORATORY TEST; LOADING DRUG DOSE; MENINGITIS; MENINGOCOCCOSIS; MENTAL DISEASE; METABOLIC ENCEPHALOPATHY; MUTISM; NAUSEA AND VOMITING; NEGLECT; NEUROSYPHILIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUADRIPLEGIA; RADIOGRAPHY; REVIEW; SENSORY DYSFUNCTION; STROKE; TOXOPLASMOSIS; TREATMENT DURATION; TUBERCULOMA; TUBERCULOUS MENINGITIS; UREA NITROGEN BLOOD LEVEL; VIRUS LOAD; VIRUS MENINGITIS; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; COMORBIDITY; CONSCIOUSNESS DISORDER; EMERGENCY MEDICINE; EMERGENCY TREATMENT; EPIDEMIOLOGY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOLOGY; METHODOLOGY;

AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSALITY; CENTRAL NERVOUS SYSTEM INFECTIONS; COMORBIDITY; CONSCIOUSNESS DISORDERS; DIAGNOSIS, DIFFERENTIAL; EMERGENCY MEDICINE; EMERGENCY TREATMENT; HIV INFECTIONS; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MEDICAL HISTORY TAKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77952469515     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2010.01.012     Document Type: Review

References (24)

1. Mamidi A., DeSimone J.A., Pomerantz R.J. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol 2002, 8(3):158-167.
2. Treisman G.J., Kaplin A.I. Neurologic and psychiatric complications of antiretroviral agents. AIDS 2002, 16(9):1201-1215.
3. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002, 8(Suppl 2):115-121.
4. Riedel D.J., Pardo C.A., McArthur J.C., et al. Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol 2006, 2(10):557-565.
5. Janssen R.S., Cornblath D.R., Epstein L.G., et al. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology 1989, 39(1):119-122.
6. Kanzer M.D. Neuropathology of AIDS. Crit Rev Neurobiol 1990, 5(4):313-362.
7. Centers for Disease Control and Prevention Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2009, 58(No. RR04):1-198.
8. Portegies P., Solod L., Cinque P., et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol 2004, 11(5):297-304.
9. Manji H., Miller R. The neurology of HIV infection. J Neurol Neurosurg Psychiatr 2004, 75(Suppl 1):i29-i35.
10. Murdoch D.M., Venter W.D.F., Van Rie A., et al. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007, 4:9.
11. Clifford D.B., Yang Y., Evans S. Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection. J Neurovirol 2005, 11(Suppl 3):67-71.
12. Rothman R.E., Keyl P.M., McArthur J.C., et al. A decision guideline for emergency department utilization of noncontrast head computerized tomography in HIV-infected patients. Acad Emerg Med 1999, 6(10):1010-1019.
13. Tso E.L., Todd W.C., Groleau G.A., et al. Cranial computed tomography in the emergency department evaluation of HIV-infected patients with neurologic complaints. Ann Emerg Med 1993, 22(7):1169-1176.
14. Smith A.B., Smirniotopoulos J.G., Rushing E.J. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008, 28(7):2033-2058.
15. Saag M.S., Graybill R.J., Larsen R.A., et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000, 30(4):710-718.
16. Spudich S.S., Nilsson A.C., Lollo N.D., et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis 2005, 5:98.
17. Arribas J.R., Storch G.A., Clifford D.B., et al. Cytomegalovirus encephalitis. Ann Intern Med 1996, 125(7):577-587.
18. Romanelli F., Ryan M. Seizures in HIV-seropositive individuals: epidemiology and treatment. CNS Drugs 2002, 12(2):91-98.
19. Liedtke M.D., Lockhart S.M., Rathbun R.C. Anticonvulsant and antiretroviral interactions. Ann Pharmcother 2004, 38(3):482-489.
20. McNichol IR, editor. HIVInSite database of antiretroviral drug interactions. Available at: Accessed August 17, 2009. http://hivinsite.ucsf.edu/arvdb?page=ar-0002.
21. Centers for Disease Control and Prevention Treatment of tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR 2003, 52(RR11):1-77.
22. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39(9):1267-1284.
23. Prasad K., Singh S.B. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008, (1). CD002244., CD002244.pub3. doi:10.1002/14651858.
24. Scarborough M., Gordon S.B., Whitty C.J.M., et al. Corticosteroids for bacterial meningitis in adults in Sub-Saharan Africa. N Engl J Med 2007, 357(24):2441-2450.